Kwang Dong Pharmaceutical
Scope
Date
~
-
Bio & Pharma
Daewoong submits new drug applications for Fexuclue in 10 countries
South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean Proteina gets offers from global pharmaceutical companies
Global pharmaceutical companies are expressing keen interest in the South Korean diagnostics company Proteina. Unlike companies that search for sp...
Dec 12, 2022 (Gmt+09:00)
-
Bio & Pharma
Boryung holds Care-in-Space Challenge in US for space healthcare startups
South Korea's pharmaceutical company Boryeong said on Friday that it held the first "Care-in-Space Challenge" event, a new space healthcare startup ...
Dec 09, 2022 (Gmt+09:00)
-
Banking & Finance
Korea Shinhan Financial taps banking unit head as group CEO
Shinhan Financial Group appointed the head of its flagship banking unit as the group’s next chief executive officer as the major South Korean ...
Dec 08, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea approves Daewoong Pharmaceutical's diabetes drug
DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight ye...
Dec 02, 2022 (Gmt+09:00)
-
Food & Beverage
Daesang Welllife forms joint venture with Sinopharm Group
Daesang Welllife on Thursday said it has concluded a memorandum of understanding (MOU) with China Sinopharm International, an affiliate of China's l...
Dec 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharmaceutical relocates US research center from Seattle to Boston
JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...
Nov 23, 2022 (Gmt+09:00)
-
Entertainment
Squid Game wins Emmy awards for best actor, director
LOS ANGELES, California -- Netflix mega-hit Squid Game star Lee Jung-jae and creator Hwang Dong-hyuk each bagged an Emmy trophy Monday night in Los ...
Sep 13, 2022 (Gmt+09:00)
-
Private equity
Seoul sees high odds of reversing Lone Star-favoring ruling
South Korea’s justice ministry expressed confidence in winning an appeal against an international ruling that accepted part of Lone Star&rsquo...
Sep 02, 2022 (Gmt+09:00)
-
Leadership & Management
Hanwha's heir apparent promoted as group's vice chair
South Korea’s Hanwha Group promoted its petrochemical and energy unit Hanwha Solutions Corp. CEO Kim Dong Kwan as the group’s new vice c...
Aug 29, 2022 (Gmt+09:00)
-
Korean startups
Voyager X plans to beat conglomerates by executing weird, unique ideas
Voyager X is a relatively new artificial intelligence (AI) startup in South Korea. Its founder Nam Se-dong, however, has been a well-known figu...
Jul 31, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Corporate investment
LG eyes clean tech supremacy with $1.5 bn spending on green projects
South Korea’s fourth-largest conglomerate LG is setting its sights on clean energy technology as it steps up efforts to transform into an eco-...
Jun 30, 2022 (Gmt+09:00)
language -
Bio & Pharma
SK's biotech bets step closer to commercialization
Biotechnology startups in Europe, backed by South Korea's SK Inc., are speeding up their development of next-generation drug candidates by joining h...
Apr 15, 2022 (Gmt+09:00)
-
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
Bio
K-bio's out-licensing this year reaches $9.3 bn
Overseas technology transfers from South Korean biotechs and pharmaceutical manufacturers this year have exceeded 11 trillion won ($9.3 billion), al...
Nov 18, 2021 (Gmt+09:00)
language -
Pension funds
POBA seeks new CIO as Jang Dong-hun's term ends in Jan 2022
South Korea’s Public Officials Benefit Association (POBA) is looking for a new chief investment officer (CIO) as the term of current CIO Jang ...
Nov 03, 2021 (Gmt+09:00)
-
Music & Entertainment
Squid Game: Bloody battle for survival reflects reality – director
Netflix original South Korean drama “Squid Game” is making history again for K-content, topping the platform’s global chart as the...
Sep 29, 2021 (Gmt+09:00)
language -
Biotech
Korea’s bio startup Voronoi inks $324 million deal with Brickell Biotech
Voronoi Inc., a South Korean biotechnology startup, has clinched a $324 million deal to grant Brickell Biotech, a US clinical-stage pharmaceutical f...
Sep 02, 2021 (Gmt+09:00)
language -
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language -
(DO NOT EDIT)CAPA: Korean mold maker Dong-A ENG advances with green mobility
CAPA: Dong-A ENG Co. (company logo) Key facts - Main business: Industrial mold design and manufacturing/machinery manufacturing- Mainstay products/s...
1 MINUTES AGO